[A case of small intestinal cancer with peritoneal metastases treated with FOLFOX regimen].
A38 -year-old man complaining of abdominal pain was diagnosed with small intestinal cancer. Small intestinal endoscopy and PET-CT showed a primary jejunal cancer and five peritoneal metastases. Partial resection of the jejunum with three metastases was performed, but the others were unresectable. After surgery, FOLFOX chemotherapy was adapted. Follow-up pelvic CT showed a remarkable reduction of tumor size during FOLFOX chemotherapy after 4 courses, and follow-up PET-CT showed no tumor intake FDG after 10 courses. We judged him to be a complete response and stopped chemotherapy. After 7 months, the patient's level of tumor markers elevated, and there was recurrence. We resumed FOLFOX, and the chemotherapy for this patient is still being continued.
Dept. of Surgery, Tokyo Metropolitan Bokutoh Hospital, Japan.
Kentaro
K
Inada
Tsuyoshi
T
Maeshiro
Dai
D
Shida
Yasuji
Y
Seyama
Sachio
S
Miyamoto
Satoru
S
Inoue
Nobutaka
N
Umekita
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007580:Jejunal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002955:Leucovorin / Q000627:therapeutic use; D008297:Male; D009361:Neoplasm Invasiveness; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000556:secondary; D012008:Recurrence
D009944:Organoplatinum Compounds; D002955:Leucovorin; D005472:Fluorouracil